Jacobs Levy Equity Management’s Biohaven BHVN Stock Holding History

Jacobs Levy Equity Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30,080	Closed	-$254K	–	962
2026 Q1	$254K	Buy	+30,080	New	+$329K	﹤0.01%	894
2024 Q3	–	Sell	-16,500	Closed	-$573K	–	964
2024 Q2	$573K	Buy	+16,500	New	+$652K	﹤0.01%	820
2023 Q4	–	Sell	-36,155	Closed	-$940K	–	978
2023 Q3	$940K	Buy	+36,155	New	+$751K	0.01%	688

Other funds holding BHVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management's BHVN Position: Q2 2026 in Review

Jacobs Levy Equity Management sold out of Biohaven (BHVN) in Q2 2026, closing a stake of 30,080 shares — an estimated $254K sold.

Jacobs Levy Equity Management first reported a position in BHVN in Q3 2023 and held it in 3 quarters. The position peaked at $940K in Q3 2023. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

Jacobs Levy Equity Management reported no remaining Biohaven position as of Q2 2026 after selling out during the quarter.
Jacobs Levy Equity Management sold 30,080 Biohaven shares in Q2 2026, an estimated $254K.
Jacobs Levy Equity Management first reported a position in Biohaven in Q3 2023 and held it in 3 quarters.
Jacobs Levy Equity Management's Biohaven position peaked at $940K in Q3 2023.
292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.